drugset / Trial / NCT04944771

Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants

NCT04944771

Phase 1 Completed 48 enrolled AstraZeneca Parexel · collab
RandomizedCrossoverOpen-labelTreatment

Summary

This is a two-part, open-label, randomized, crossover study in healthy subjects (vasectomized males and women of non-childbearing potential), performed at 2 study centers

Timeline

Start
2021-07-26
Primary completion
2022-05-04
Completion
2022-05-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Capivasertib Small molecule Oral
Background Rabeprazole Small molecule Oral